Detalhe da pesquisa
1.
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.
Proc Natl Acad Sci U S A
; 114(30): E6231-E6239, 2017 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28701380
2.
Ketamine Abuse Syndrome: Hepatobiliary and Urinary Pathology Among Adolescents in Flushing, NY.
Pediatr Emerg Care
; 33(8): e24-e26, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26247263
3.
Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells.
bioRxiv
; 2024 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38559242
4.
Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
Bioorg Med Chem Lett
; 22(8): 2968-72, 2012 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22437115
5.
Development of an intracellular quantitative assay to measure compound binding kinetics.
Cell Chem Biol
; 29(2): 287-299.e8, 2022 02 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34520747
6.
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432.
J Med Chem
; 65(22): 15174-15207, 2022 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36378954
7.
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral Candidate.
J Med Chem
; 65(3): 2262-2287, 2022 02 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34995458
8.
Acylglycinamides as inhibitors of glycine transporter type 1.
Bioorg Med Chem Lett
; 21(20): 6176-9, 2011 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21889344
9.
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors.
ACS Med Chem Lett
; 12(8): 1308-1317, 2021 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34413961
10.
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors.
J Med Chem
; 64(15): 10711-10741, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34260229
11.
Optimization of a Series of RIPK2 PROTACs.
J Med Chem
; 64(17): 12978-13003, 2021 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34432979
12.
Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors.
J Med Chem
; 64(6): 3249-3281, 2021 03 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33662213
13.
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.
J Med Chem
; 64(15): 10772-10805, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34255512
14.
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression.
J Med Chem
; 64(16): 12200-12227, 2021 08 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34387088
15.
5-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-2(1H)-quinolinones and 3,4-dihydro-2(1H)-quinolinones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors. Part 3.
Bioorg Med Chem Lett
; 20(23): 7092-6, 2010 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20951584
16.
The sequence and analysis of duplication-rich human chromosome 16.
Nature
; 432(7020): 988-94, 2004 Dec 23.
Artigo
Inglês
| MEDLINE | ID: mdl-15616553
17.
The DNA sequence and comparative analysis of human chromosome 5.
Nature
; 431(7006): 268-74, 2004 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-15372022
18.
The DNA sequence and biology of human chromosome 19.
Nature
; 428(6982): 529-35, 2004 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15057824
19.
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins.
J Med Chem
; 63(17): 9045-9069, 2020 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32691589
20.
Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study.
Lancet Child Adolesc Health
; 4(10): 721-727, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32711687